CURE Pharmaceutical Revenue and Competitors



Total Funding



Estimated Revenue & Valuation

  • CURE Pharmaceutical's estimated annual revenue is currently $15.3M per year.(i)
  • CURE Pharmaceutical's estimated revenue per employee is $299,382
  • CURE Pharmaceutical's total funding is $29M.

Employee Data

  • CURE Pharmaceutical has 51 Employees.(i)
  • CURE Pharmaceutical grew their employee count by 42% last year.

CURE Pharmaceutical's People

Chief Accounting OfficerReveal Email/Phone
CEO CureReveal Email/Phone
Chief Business OfficerReveal Email/Phone
Chief Scientific OfficerReveal Email/Phone
Chief Operating OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

What Is CURE Pharmaceutical?

CURE Pharmaceutical is an innovative drug delivery and development company committed to improving drug efficacy, safety and the patient experience through its proprietary drug dosage forms and delivery systems. CURE has an industry leading full-service cGMP manufacturing facility and is a preeminent developer and manufacturer of a patented and proprietary delivery system (CureFilm?), the most advanced oral thin film on the market today. CURE has developed an array of products in cutting-edge delivery platforms and partners with leading pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada, Israel and Germany, among other markets. Our mission is to improve people's lives by redefining how medicines are delivered and experienced.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





CURE Pharmaceutical News

2022-04-17 - Where Will Cure Pharmaceutical Holding Corp (CURR) Stock Go Next After It Is Higher By 30.43% in a Week?

Cure Pharmaceutical Holding Corp (CURR) stock has risen 30.43% over the past week and gets a Bullish rating from InvestorsObserver Sentiment...

2022-04-06 - Do Traders Think Cure Pharmaceutical Holding Corp (CURR) Can Turn Around Friday?

The market has been down on Cure Pharmaceutical Holding Corp (CURR) stock recently. CURR gets a Bearish score from InvestorsObserver Stock...

2022-03-22 - Can Cure Pharmaceutical Holding Corp (CURR) Stock Rise to the Top of Healthcare Sector Friday?

Additionally, Cure Pharmaceutical Holding Corp scored a 6 in the Healthcare sector, ranking it higher than 6% of stocks in that sector. Overall...

2020-11-02 - CURE Pharmaceutical Closes $10M Financing

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holdings (OTC: CURR), a developer and manufacturer of innovative delivery formulations for drugs, supplements and wellness products, today announced that it has received the first tranche of $4 million of a committed financing of $10 million, ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding